- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02425124
Strengthening Mental Health Care in Chronic Care Patients With Hypertension. A Cluster Randomised Control Trial
April 16, 2019 updated by: Inge Petersen, University of KwaZulu
A pragmatic cluster randomized controlled trial (RCT) in 20 public sector primary care clinics in the Dr Kenneth Kaunda district of the North West Province of South Africa to assess mental health and health outcomes for depressed adults receiving hypertensive treatment by measuring the real-world effectiveness of a facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.
The control condition is enhanced usual primary health care where non-physician clinicians have been equipped with the basic skills to identify stress and depression/anxiety but with limited access to doctors authorized to prescribe antidepressant medication, and with no specific psychosocial interventions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Cardiovascular disease (hypertension and stroke) is the leading cause of mortality in the world and the second leading cause of death in Africa.
Estimates by the WHO using disability adjusted life years (DALYs) suggest that NCDs were responsible for 28% of the total burden of disease in South Africa in 2004, with heart disease, diabetes and stroke together being responsible for the second most important cause of death in adult South Africans.
In the investigators 2014 survey of 3 primary health care facilities in the North West Province where the Department of Health is piloting Integrated Chronic Disease Management the investigators found that of the 1 250 chronic care patients surveyed, 51% reported having hypertension.
Spurring the rising burden of NCDs are mental disorders.
One in 6 adults experience a common mental disorder (depression, anxiety disorders and substance use disorders) within a 12 month period (Herman et al., 2009), one in four receive treatment of any kind (Seedat et al., 2009).
Depression co-exists with NCDs having a mutually reinforcing relationship compromising both prevention and treatment through exacerbating modifiable risk factors and compromising adherence and self-care respectively.
Objectives: The investigators propose to strengthen the Primary Care 101 guidelines.
This is a set of clinical guidelines and decision support for nurses developed for the identification and management of multiple chronic diseases.
Study Type
Interventional
Enrollment (Actual)
1052
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North West Province
-
Dr Kenneth Kaunda District, North West Province, South Africa, 2577
- Primary Health Care Facilities
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Clinics
- Twenty (20) largest clinics providing chronic care Patients
- Receiving hypertensive treatment at time of enrolment
- Depressive symptoms as indicated by total score of 9 or more on PHQ-9
- Planning to reside in area for the next year
- Capable of actively engaging in interviewer-administered questionnaire at time of recruitment, 6 months and 12 months later
- Written consent to participate in the study
Exclusion Criteria:
Clinics
- Clinics that do not provide Integrated Chronic Disease Management
- Small (<10 000 attendances/ year)
- Mobile or satellite
- Participated in piloting of intervention & data collection. Patients
- Inability to meet the above inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
PC101 Enhanced usual primary health care where non-physician clinicians have been equipped with the basic skills to identify stress and depression/anxiety but with limited access to doctors authorized to prescribe antidepressant medication, and with no specific psychosocial interventions.
|
Facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.
|
|
Experimental: Intervention
PC101 + Mental Health Facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.
|
Facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression
Time Frame: 6 Months
|
50 % reduction in PHQ-9 score
|
6 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression
Time Frame: 12 months
|
50 % reduction in the PHQ-9 score
|
12 months
|
|
Depression
Time Frame: 12 months
|
Remission defined as score of <5 on PHQ9
|
12 months
|
|
Depression
Time Frame: 6 months; 12 months
|
Mean PHQ9 scores
|
6 months; 12 months
|
|
Blood pressure
Time Frame: 6 months and 12 months
|
Difference in means
|
6 months and 12 months
|
|
Disability
Time Frame: 12 Months
|
Mean score using the Manual for WHO Disability Schedule WHODAS 2.0 schedule
|
12 Months
|
|
Stress
Time Frame: 12 Months
|
Mean score using Perceived Stress Scale
|
12 Months
|
|
Antidepressant treatment
Time Frame: 12 months
|
Proportion with antidepressant treatment initiated or intensified
|
12 months
|
|
Counselling
Time Frame: 12 months
|
Proportion receiving counselling by clinic-based counsellor
|
12 months
|
|
Referral to specialist mental health worker/service
Time Frame: 12 months
|
Proportion referred
|
12 months
|
|
Retention in care
Time Frame: 12 months
|
Proportion in care
|
12 months
|
|
Cardiovascular risk factors
Time Frame: 12 months
|
Difference in means
|
12 months
|
|
Diagnosis of other comorbid illnesses
Time Frame: 12 months
|
Proportion diagnosed
|
12 months
|
|
Quality of chronic illness care received
Time Frame: 12 months
|
Mean Patient Assessment of Care for Chronic Conditions (PACIC) score
|
12 months
|
|
Healthcare utilization
Time Frame: 12 months
|
Incidence rate ratio using linkage with hospitalisation databases
|
12 months
|
|
Productivity and economic outcomes
Time Frame: 12 months
|
Productivity and economic outcomes
|
12 months
|
|
All cause mortality
Time Frame: 12 months
|
Proportion died
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Graham Thornicroft, PhD, King's College London
- Principal Investigator: Inge Petersen, PhD, University of KwaZulu
- Principal Investigator: Lara R Fairall, PhD, University of Cape Town
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Petersen I, Fairall L, Zani B, Bhana A, Lombard C, Folb N, Selohilwe O, Georgeu-Pepper D, Petrus R, Mntambo N, Kathree T, Bachmann M, Levitt N, Thornicroft G, Lund C. Effectiveness of a task-sharing collaborative care model for identification and management of depressive symptoms in patients with hypertension attending public sector primary care clinics in South Africa: pragmatic parallel cluster randomised controlled trial. J Affect Disord. 2021 Mar 1;282:112-121. doi: 10.1016/j.jad.2020.12.123. Epub 2020 Dec 28. Erratum In: J Affect Disord. 2021 May 1;286:370.
- Petersen I, Bhana A, Folb N, Thornicroft G, Zani B, Selohilwe O, Petrus R, Mntambo N, Georgeu-Pepper D, Kathree T, Lund C, Lombard C, Bachmann M, Gaziano T, Levitt N, Fairall L; PRIME-SA research team. Collaborative care for the detection and management of depression among adults with hypertension in South Africa: study protocol for the PRIME-SA randomised controlled trial. Trials. 2018 Mar 22;19(1):192. doi: 10.1186/s13063-018-2518-6.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 22, 2015
Primary Completion (Actual)
October 31, 2016
Study Completion (Actual)
July 31, 2017
Study Registration Dates
First Submitted
April 10, 2015
First Submitted That Met QC Criteria
April 22, 2015
First Posted (Estimate)
April 23, 2015
Study Record Updates
Last Update Posted (Actual)
April 17, 2019
Last Update Submitted That Met QC Criteria
April 16, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HRPC10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.